Human gene therapy - JoVE Visualize

Showing results (1501-1510 of 4,124) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|August 29, 2019

Helper-Dependent Adenovirus Transduces the Human and Rat Retina but Elicits an Inflammatory Reaction When Delivered Subretinally in RatsIan C Han, Erin R Burnight, Mallory J Ulferts, et al.

Human Gene Therapy|August 7, 2019

Nonviral Delivery of GRIM-19 Gene Inhibits Tumor Growth with Reduced Local and Systemic ComplicationsYang Xu, Xinghuo Wang, Baofeng Guo, et al.

Human Gene Therapy|February 4, 1998

In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2L A Bui, L H Butterfield, J Y Kim, et al.

Human Gene Therapy|March 21, 1998

Co-expression of human adenosine deaminase and multidrug resistance using a bicistronic retroviral vectorY Zhou, J Aran, M M Gottesman, et al.

Human Gene Therapy|March 21, 1998

Inhibition of human immunodeficiency virus type 1 replication in myelomonocytic cells derived from retroviral vector-transduced peripheral blood progenitor cellsU Junker, C S Kalfoglou, J J Moon, et al.

Human Gene Therapy|February 24, 1998

Effects of megakaryocyte growth and development factor on survival and retroviral transduction of T lymphoid progenitor cellsR G Amado, G Symonds, B D Jamieson, et al.

Human Gene Therapy|February 24, 1998

Delivery of recombinant gene product to canines with nonautologous microencapsulated cellsM A Peirone, K Delaney, J Kwiecin, et al.

Human Gene Therapy|February 24, 1998

Efficient transduction of hemopoietic CD34+ progenitors of human origin using an original retroviral vector derived from Fr-MuLV-FB29: in vitro assessmentO Cohen-Haguenauer, L M Restrepo, M Masset, et al.

Human Gene Therapy|February 24, 1998

Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibodyH Konishi, T Ochiya, K A Chester, et al.

Human Gene Therapy|June 2, 1998

Recombinant adeno-associated virus for the generation of autologous, gene-modified tumor vaccines: evidence for a high transduction efficiency into primary epithelial cancer cellsG Maass, C Bogedain, U Scheer, et al.

Pageof 413

Showing results (1501-1510 of 4,124) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|August 29, 2019

Helper-Dependent Adenovirus Transduces the Human and Rat Retina but Elicits an Inflammatory Reaction When Delivered Subretinally in RatsIan C Han, Erin R Burnight, Mallory J Ulferts, et al.

Human Gene Therapy|August 7, 2019

Nonviral Delivery of GRIM-19 Gene Inhibits Tumor Growth with Reduced Local and Systemic ComplicationsYang Xu, Xinghuo Wang, Baofeng Guo, et al.

Human Gene Therapy|February 4, 1998

In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2L A Bui, L H Butterfield, J Y Kim, et al.

Human Gene Therapy|March 21, 1998

Co-expression of human adenosine deaminase and multidrug resistance using a bicistronic retroviral vectorY Zhou, J Aran, M M Gottesman, et al.

Human Gene Therapy|March 21, 1998

Inhibition of human immunodeficiency virus type 1 replication in myelomonocytic cells derived from retroviral vector-transduced peripheral blood progenitor cellsU Junker, C S Kalfoglou, J J Moon, et al.

Human Gene Therapy|February 24, 1998

Effects of megakaryocyte growth and development factor on survival and retroviral transduction of T lymphoid progenitor cellsR G Amado, G Symonds, B D Jamieson, et al.

Human Gene Therapy|February 24, 1998

Delivery of recombinant gene product to canines with nonautologous microencapsulated cellsM A Peirone, K Delaney, J Kwiecin, et al.

Human Gene Therapy|February 24, 1998

Efficient transduction of hemopoietic CD34+ progenitors of human origin using an original retroviral vector derived from Fr-MuLV-FB29: in vitro assessmentO Cohen-Haguenauer, L M Restrepo, M Masset, et al.

Human Gene Therapy|February 24, 1998

Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibodyH Konishi, T Ochiya, K A Chester, et al.

Human Gene Therapy|June 2, 1998

Recombinant adeno-associated virus for the generation of autologous, gene-modified tumor vaccines: evidence for a high transduction efficiency into primary epithelial cancer cellsG Maass, C Bogedain, U Scheer, et al.

Pageof 413